SCHEMBL30895880

SCHEMBL30895880

Nc1ccc(Sc2nc3ccccc3s2)c(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSD P07339 2/20 0.52
▸ HSPD1 P10809 2/20 0.50
▸ HSPE1 P61604 2/20 0.50
▸ FBP1 P09467 2/20 0.49
▸ ALOX15 P16050 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ ADRA2A P08913 1/20 0.49
▸ ADORA3 P0DMS8 1/20 0.49
▸ DRD2 P14416 1/20 0.49
▸ HPGD P15428 1/20 0.49
▸ ADRA2B P18089 1/20 0.49
▸ ADRA2C P18825 1/20 0.49
▸ DRD1 P21728 1/20 0.49
▸ MC5R P33032 1/20 0.49
▸ OPRM1 P35372 1/20 0.49
▸ DRD3 P35462 1/20 0.49
▸ OPRK1 P41145 1/20 0.49
▸ CCR2 P41597 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19840432 1.00 CTSD (0.52) CTSDHSPD1HSPE1FBP1ALOX15
SCHEMBL19840133 0.83 MAPT (0.53) CTSDHSPD1HSPE1FBP1ALOX15
SCHEMBL12584929 0.82 PDE7A (0.45) ALDH1A1MAPTKMT2ATSHRITGB2
SCHEMBL24438715 0.80 CTSD (0.60) CTSDHSPD1HSPE1FBP1ALOX15
SCHEMBL2032205 0.80 PPARA (0.46) CTSDHSPD1HSPE1HSD17B10ALDH1A1
SCHEMBL2031038 0.80 APP (0.52) CTSDALDH1A1MAPTKMT2ANPC1
SCHEMBL2035992 0.80 ILK (0.42) CTSDHSPD1HSPE1TDP1ALDH1A1
Hydrochloric Acid SCHEMBL10787996 0.79 CTSD (0.51) CTSDFBP1ALOX15HSD17B10TDP1
SCHEMBL24118868 0.78 KMT2A (0.57) CTSDHSPD1HSPE1TDP1ALDH1A1
SCHEMBL8563621 0.76 FBP1 (0.58) CTSDHSPD1HSPE1FBP1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122029161-A Crystalline forms of PI3K inhibitors and uses thereof 蝎子疗法股份有限公司 2026-05-12 — — CN disclosed
EP-4611748-A1 COMBINATION THERAPY FOR TREATING CANCER Scorpion Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2025038698-A1 CRYSTALLINE FORMS OF A PI3K INHIBITOR AND USES OF SAME SCORPION THERAPEUTICS, INC. (US) 2025-02-20 — — WO disclosed
WO-2024097636-A1 COMBINATION THERAPY FOR TREATING CANCER SCORPION THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback